Advanced Therapy of Inflammatory Bowel Disease

Front Cover
PMPH-USA, 2001 - Medical - 670 pages
0 Reviews
The main emphasis of this new edition is on diagnosis, therapy and patient management, along with disease activity measures, IBD databases, and the use of diagnostic tests in clinical decision making. Each chapter consists of recommendations from an expert in the field concerning a very specific IBD topic. Precise recommendations for instituting, modifying, and monitoring therapy as well as how complications can be anticipated, prevented and treated are offered. Key Features new co-editor, experienced clinician, Stephen B. Hanauer 48 NEW medical and surgical IBD topics one of the most CLINICALLY USEFUL books in gastroenterology outlines advantages and disadvantages of various drugs, and therapeutic or diagnostic procedures covers 140 well-defined situations encountered in patients with IBD
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

PATIENTDOCTOR INTERACTIONS
1
PEDIATRIC PATIENT FAMILY DOCTOR INTERACTIONS
5
ADHERENCE ISSUES IN MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
9
MANAGING INFLAMMATORY BOWEL DISEASE IN THE MANAGED CARE ERA
13
MEDICALSURGICAL COLLABORATION IN PATIENT MANAGEMENT
19
CONSULTATIONS AND THE PATIENT WITH INFLAMMATORY BOWEL DISEASE
23
MEASURES OF DISEASE ACTIVITY
25
COMPUTER DATABASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
29
CROHNS DISEASE THERAPEUTIC IMPLICATIONS OF DISEASE SUBTYPES
333
THERAPEUTIC EXPECTATIONS OF MEDICAL MANAGEMENT OF CROHNS DISEASE
337
SEQUENTIAL AND COMBINATION THERAPY FOR SMALL BOWEL DISEASE
343
ORAL 5AMINOSALICYLIC ACID MEDICATIONS IN CROHNS DISEASE
347
CLINICAL QUESTIONS IN CROHNS DISEASE NOT ANSWERED BY CONTROLLED TRIALS
353
ANTIBIOTICS AS THERAPEUTIC AGENTS IN CROHNS DISEASE
359
APPROPRIATE USE OF CORTICOSTEROIDS IN INFLAMMATORY BOWEL DISEASE
363
TOPICALLY ACTIVE STEROID PREPARATIONS
367

USEFUL BIOLOGIC MARKERS AS ACTIVITY INDICES
35
IMAGING OF MUCOSAL INFLAMMATION
39
CROHNS DISEASE COMPUTED TOMOGRAPHIC SCANNING IN CLINICAL DECISIONMAKING
47
TRANSABDOMINAL BOWEL SONOGRAPHY IN CLINICAL DECISIONMAKING
55
MODE OF ACTION OF ANTIINFLAMMATORY AGENTS
63
MANAGEMENT OF DISTAL COLITIS
69
TOPICALLY ACTIVE CORTICOSTEROIDS FOR COLITIS
73
PSEUDOINTRACTABILITY OF INFLAMMATORY BOWEL DISEASE
77
REFRACTORY DISTAL COLITIS
81
COEXISTENCE OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME
87
COEXISTENT IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE
91
INFECTIOUS AGENTS AS AGGRAVATING FACTORS IN INFLAMMATORY BOWEL DISEASE
95
USE OF NICOTINE AND TOBACCO IN COLITIS
99
IMMUNOMODULATOR USE IN PATIENTS WITH DISTAL COLITIS
103
MUCOSAL PROTECTIVE AND REPAIR AGENTS IN THE TREATMENT OF COLITIS
107
THERAPEUTIC EXPECTATIONS MEDICAL MANAGEMENT OF ULCERATIVE COLITIS
111
SEQUENTIAL AND COMBINATION THERAPY OF ULCERATIVE COLITIS
115
ULCERATIVE COLITIS A DIVERSE DISEASE WITH DIVERSE QUESTIONS AND DIVERSE SOLUTIONS
119
AMINOSALICYLATES THERAPY FOR ULCERATIVE COLITIS
123
SYSTEMIC CORTICOSTEROIDS IN INFLAMMATORY BOWEL DISEASE
127
STEROID UNRESPONSIVENESS IN INFLAMMATORY BOWEL DISEASE
133
IMMUNOMODULATORS IN ULCERATIVE COLITIS
139
MANAGEMENT OF SEVERE ULCERATIVE COLITIS
143
USE OF ANTIBIOTICS AND OTHER ANTI INFECTIOUS AGENTS IN ULCERATIVE COLITIS
149
MANAGEMENT OF ULCERATIVE COLITIS IN CHILDREN
153
INDETERMINATE COLITIS
157
DIETARY RECOMMENDATIONS FOR ACTIVE AND INACTIVE ULCERATIVE COLITIS
161
NOVEL MANIPULATIONS OF INFLAMMATORY MEDIATOR PATHWAYS
165
THERAPEUTIC EXPECTATIONS SURGICAL MANAGEMENT OF ULCERATIVE COLITIS
171
INDICATIONS FOR COLECTOMY AND CHOICE OF PROCEDURES
175
ROLE OF THE ENTEROSTOMAL THERAPY NURSE
179
BROOKE ILEOSTOMY
185
CONTINENT ILEOSTOMY KOCK POUCH
191
ILEOANAL POUCH ANASTOMOSIS
197
LONGTERM RESULTS WITH ILEOANAL POUCH
203
ILEOANAL POUCH EVALUATION OF EXCESSIVE BOWEL MOVEMENTS
209
ILEOANAL POUCH SURGERY IN CHILDHOOD
215
CHRONIC POUCHITIS
219
ENDOSCOPY IN EVALUATING ILEAL POUCHES
225
ROLE OF THE PATHOLOGIST IN EVALUATING CHRONIC POUCHES
229
SUPPORT FOR PATIENTS WHO UNDERGO OSTOMY AND POUCH SURGERY
233
ILEORECTAL ANASTOMOSIS
237
INDETERMINATE COLITIS SURGICAL APPROACHES
241
GROWTH AND NUTRITIONAL PROBLEMS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
245
DYSPLASIA SURVEILLANCE PROGRAMS
251
CANCER PREVENTION STRATEGIES IN INFLAMMATORY BOWEL DISEASE
257
DYSPLASIA SURVEILLANCE IN CROHNS DISEASE
263
EXTRAINTESTINAL MANIFESTATIONS
267
CUTANEOUS MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
271
OCULAR MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
275
ARTHRITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
279
LESSONS FROM TREATMENT OF RHEUMATOID ARTHRITIS
283
OSTEOPENIA AND OSTEOPOROSIS PREVENTION AND TREATMENT
289
ISCHEMIC NECROSIS OF BONE
293
SCLEROSING CHOLANGITIS
299
STRICTURE MANAGEMENT IN PRIMARY SCLEROSING CHOLANGITIS
303
LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
305
CHOLANGIOCARCINOMA IN THE INFLAMMATORY BOWEL DISEASE PATIENT
311
GALLSTONE MANAGEMENT IN INFLAMMATORY BOWEL DISEASE
317
UROLOGIC COMPLICATIONS
321
HEMATOLOGIC PROBLEMS IN INFLAMMATORY BOWEL DISEASE
325
PANCREATITIS IN INFLAMMATORY BOWEL DISEASE
329
AZATHIOPRINE AND 6MERCAPTOPURINE USE IN CROHNS DISEASE
373
AZATHIOPRINE METABOLISM IN INFLAMMATORY BOWEL DISEASE CORRELATION WITH EFFICACY AND TOXICITY
377
METHOTREXATE IN INFLAMMATORY BOWEL DISEASE
383
CYCLOSPORINE IN CROHNS DISEASE
387
ANTICYTOKINE THERAPY IN CROHNS DISEASE
389
PERIANAL FISTULA
395
OPTIONS IN MANAGING ENTERAL FISTULAE IN INFLAMMATORY BOWEL DISEASE
401
BOWEL REST AND PARENTERAL NUTRITION
405
ENTERAL NUTRITION AND DIETARY MANAGEMENT
409
CROHNS DISEASE IN CHILDREN AND ADOLESCENTS
415
GASTRODUODENAL CROHNS DISEASE
421
CROHNS JEJUNOILEITIS
425
MEDICAL THERAPY OF CROHNS COLITIS
429
FISTULIZING AND PERFORATING CROHNS DISEASE
435
THERAPEUTIC EXPECTATIONS SURGICAL MANAGEMENT OF CROHNS DISEASE
439
INDICATIONS AND PROCEDURES FOR SURGERY OF SMALL BOWEL CROHNS DISEASE
443
PERIOPERATIVE NUTRITION SUPPORT
449
LAPAROSCOPICALLY ASSISTED BOWEL RESECTION
453
SURGERY FOR CROHNS DISEASE STRICTUREPLASTY
457
GASTRODUODENAL CROHNS DISEASE SURGICAL MANAGEMENT
461
MEASURES TO MINIMIZE POSTOPERATIVE RECURRENCES OF CROHNS DISEASE
465
DIARRHEA FOLLOWING SMALL BOWEL RESECTION
471
HYPEROXALURIA AND NEPHROLITHIASIS
475
CLINICAL MANAGEMENT OF SHORTBOWEL SYNDROME
479
INTESTINAL TRANSPLANTATION
485
MANAGEMENT OF POSTOPERATIVE FISTULAE
491
SURGERY FOR CROHNS COLITIS
495
PERIANAL DISEASE
501
ENDOSCOPIC MANAGEMENT OF SMALL BOWEL ANASTOMOTIC AND COLONIC STRICTURES IN CROHNS DISEASE
509
RECTOVAGINAL FISTULAE
515
FATE OF EXCLUDED BOWEL
519
INFLAMMATORY BOWEL DISEASE GENETICS
523
MANAGING PATIENTS CONCERNS
527
LIFESTYLE ISSUES AND INFLAMMATORY BOWEL DISEASE
531
INFLAMMATORY BOWEL DISEASE NURSE ADVOCATE
535
CROHNS COLITIS FOUNDATION OF AMERICA INFORMATION AND SUPPORT SERVICES
539
PEDIATRIC PATIENT AND FAMILY SUPPORT
543
NUTRITIONAL CONSULTATION AND GUIDANCE
547
QUESTIONS FREQUENTLY ASKED OF A SUPPORT SERVICE
551
INSURANCE AND DISABILITY ADVOCACY ISSUES IN INFLAMMATORY BOWEL DISEASE
555
SEXUAL ADJUSTMENTS AND BODY IMAGE
561
ROLE OF CLERGY AND THE PATIENT WITH CHRONIC DISEASE
565
APPRECIATION OF PSYCHOSOCIAL FACTORS
569
PSYCHIATRIC COMPLICATIONS OF INFLAMMATORY BOWEL DISEASE
573
PSYCHOLOGICAL PERSPECTIVES ON THE CARE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
577
STRESS MANAGEMENT
583
BEHAVIORAL PAIN MANAGEMENT
587
PAIN MANAGEMENT
593
FITNESS PROGRAMS
599
ALTERNATIVE PATIENT CARE METHODS
603
FERTILITY AND PREGNANCY IN INFLAMMATORY BOWEL DISEASE
607
PREGNANCY AND INFLAMMATORY BOWEL DISEASE
613
COLITIS IN THE ELDERLY
619
NONSTEROIDAL ANTIINFLAMMATORY DRUGS ENTEROCOLONIC ULCERATION AND INFLAMMATORY BOWEL DISEASE
625
COLLAGENOUS AND LYMPHOCYTIC COLITIS
631
RADIATION ENTEROCOLITIS
635
COLITIS AND ENTERITIS IN IMMUNOCOMPROMISED INDIVIDUALS
639
LYMPHOMA IN INFLAMMATORY BOWEL DISEASE
645
GASTROINTESTINAL COMPLICATIONS IN STEM CELL TRANSPLANTATION
649
BEHCETS DISEASE
655
THERAPY OF ULCERATIVE JEJUNOILEITIS
659
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information